west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "LI Binghui" 9 results
  • EXPERIMENTAL AND CLINICAL STUDIES ON EFFECT OF FUJIGUNING OINTMENT AND EPIDERMAL GROWTH FACTOR ON WOUNDS WITH BONE EXPOSED

    Objective To investigate the effect of Fujiguning Ointment and epidermal growth factor (EGF) on the wounds with bone exposed. Methods Forty-five rabbits were made the models of a 2 cm×5 cm wound on theback with exposure of 4 spinl process and vertebral lamina of thoracic vertebrae, and divided into 3 groupsaccording to different methods of therapy: Group A(Fujiguning OintmentEGF), Group B(Fujiguning Ointment) and Group C(normal saline). During experimental period of 60 days, the healing of wounds was observed and immunohistochemistry and in situ hybridization were employed to detect the expression of EGF/EGFR and EGF/EGFRmRNA in the granulation tissues. From February 2002 to May 2003, 23 cases of wounds with bone exposure werelocally treated with Fujiguning Ointment and EGF. First, Fujiguning Ointmentwas used to cover the wounds. After the granulation grew and covered the exposed bone, EGF was used to infiltrate the wound until the wound healed. Results The healing time of wounds with bone exposure was shorterin group A(30 days) than those in group B (45 dyas) and group C (60 dyas), showing statistically significant difference (Plt;0.01). EGF/EGFR increased significantly, the expression of EGF and EGF mRNA reached the peak at the 15th day, the expression of EGFR and EGFR mRNA reached the peak during the 15th and the 22nd days in the Fujiguning OintmentEGF group and Fujiguning Ointment group in comparison with normal saline group. Twentythree cases of wounds were cured and the average healing time was 51 days. Conclusion Fujiguning Ointment and EGF can promote the healing of the wounds with bone exposure.

    Release date:2016-09-01 09:28 Export PDF Favorites Scan
  • Application of RevMan 5.3 software for data transformation in etiological and prognostic meta-analysis

    Etiological and prognostic studies always directly reported effect size with its 95% confidence interval, hence, data transformation was needed when performing meta-analysis based on these studies. Using the data of risk ratio, hazard ratio, odds ratio and 95% confidence interval as an example, this paper introduces the process of using RevMan 5.3 software to convert data and perform meta-analysis.

    Release date:2017-07-19 10:10 Export PDF Favorites Scan
  • How to use meta package in R software to conduct meta-analysis of single nucleotide polymorphism research

    The association between single nucleotide polymorphism and disease is a typical representation of genetic association studies. Compared with the traditional dichotomous data, single nucleotide polymorphism data has its own characteristics, and 5 genetic models are commonly performed in meta-analysis. In this paper, we show how to use the " meta” package in R software to conduct meta-analysis of single nucleotide polymorphism research through examples.

    Release date:2018-01-20 10:08 Export PDF Favorites Scan
  • How to perform meta-analysis of single nucleotide polymorphism data by Review Manager 5.3 software

    To perform a meta-analysis of single nucleotide polymorphism needs to calculate gene frequency. This paper employs allele model as an example to introduce how to calculate gene frequency and display the process of a meta-analysis of single nucleotide polymorphism data using Review Manager 5.3 software.

    Release date:2019-02-19 03:52 Export PDF Favorites Scan
  • Association between periodontal disease and gastric cancer risk: a meta-analysis

    Objective To systematically review the relationship between periodontal disease and gastric cancer risk. Methods We retrieved PubMed, EMbase, CNKI, WanFang Data, VIP, and CBM databases to collect studies about the correlation between periodontal disease and gastric cancer from inception to January 31st, 2017. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then, meta-analysis was performed using RevMan 5.3 software. Results Five studies were included. The results of meta-analysis showed that there was no significant correlation between periodontal disease and gastric cancer (RR=0.99, 95%CI 0.83 to 1.19, P=0.93). Sensitivity analysis showed good stability. Subgroup analysis showed that the type of study, race and type of effect size have no statistically impact on the outcome, there was no significant correlation between periodontal disease and gastric cancer. Conclusion According to the current evidence, periodontal disease probably is not a risk factor of gastric cancer. Due to limited quality and quantity of the included studies, more high quality studies are needed to verify above conclusion.

    Release date:2017-10-16 11:25 Export PDF Favorites Scan
  • The association between periodontal disease and the incidence risk of colorectal cancer: a meta-analysis

    ObjectiveTo systematically review the association between periodontal disease and the incidence risk of colorectal cancer (CRC).MethodsPubMed, EMbase, WanFang Data and CNKI databases were searched to collect cohort studies and case-control studies for the association between periodontal disease and the incidence risk of CRC from inception to February 28th, 2017. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies, then, meta-analysis was performed by using RevMan 5.3 software.ResultsA total of 5 prospective cohort studies were included. The results from adjusted data based meta-analysis showed that the periodontal disease was not associated with the incidence risk of CRC (RR=1.14, 95%CI 0.88 to 1.49, P=0.32).ConclusionsThe current evidence suggests that periodontal disease is not associated with the risk of CRC.

    Release date:2018-03-20 03:48 Export PDF Favorites Scan
  • The efficacy of 3D laparoscopy in the treatment of colorectal cancer: a meta-analysis

    ObjectivesTo systematically review the efficacy and safety of 3D laparoscopic in the treatment of colorectal cancer.MethodsPubMed, EMbase, The Cochrane Library, CBM, VIP, WanFang Data and CNKI databases were electronically searched online to collect clinical trials of 3D laparoscopic in the treatment of colorectal cancer from inception to September 1st, 2018. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Meta-analysis was then performed using RevMan 5.3 software.ResultsA total of 26 trials, including 4 randomized controlled trials and 22 cohort studies were included. The results of meta-analysis showed that: compared with 2D laparoscopic, 3D laparoscopic had shorter operative time (MD=–16.32, 95%CI –22.61 to –10.03, P<0.000 01), less amount of blood transfusion in operation (MD=–10.80, 95%CI –19.93 to –1.66, P=0.02), more lymph node dissection (MD=0.88, 95%CI 0.30 to 1.45, P=0.003), shorter recovery time of gastrointestinal function (MD=–0.18, 95%CI –0.31 to –0.04, P=0.01), lower incidence of postoperative complication (OR=0.63, 95%CI 0.44 to 0.89, P=0.009), and fewer days in hospital (MD=–0.84, 95%CI –1.40 to –0.28, P=0.003). Additionally, there was no significant difference in hospitalization costs (MD=–0.01, 95%CI –0.23 to 0.21, P=0.94).ConclusionsCurrent evidence shows that, compared with 2D laparoscopy, 3D laparoscopy assisted colorectal cancer surgery has obvious advantages such as less bleeding during operation, shorter operation time, lower incidence of complications after operation, shorter hospitalization time and no increase in hospitalization expenses. Due to limited quality and quantity of the included studies, more high quality studies are required to verify above conclusions.

    Release date:2019-07-18 10:28 Export PDF Favorites Scan
  • An analysis of disease burden of prostate, bladder and kidney cancers attributable to smoking in China from 1990 to 2019

    ObjectiveTo analyze the disease burden of prostate, bladder and kidney cancers attributable to smoking in China from 1990 to 2019. MethodsBased on the global burden of disease study 2019, the current situation of the disease burden of prostate, bladder and kidney cancers attributable to smoking was analyzed by using the population attributable fraction (PAF), deaths and disability-adjusted life years (DALYs). Furthermore, the annual percent change (APC) and the average annual percent change (AAPC) were calculated by joinpoint regression analysis to describe the long-term trends of the smoking-attributable burden of these three cancers from 1990 to 2019. ResultsThere were an estimated 18 800 cases of deaths and 393 106 person-years of DALYs for bladder cancer caused by smoking in 2019. The age-standardized mortality and DALY rate decreased by 0.41% and 0.39% per year from 1990 to 2019, respectively. For prostate cancer, smoking was estimated to have caused 5 016 cases of deaths and 98 276 person-years of DALYs in 2019. The age-standardized mortality and DALY rate decreased by 0.28% and 0.25% per year from 1990 to 2019, respectively. For kidney cancer, the deaths and DALYs attributable to smoking were 4 935 cases and 120 620 person-years, respectively. The standardized mortality and DALY rates increased by 3.03% and 2.98% per year from 1990 to 2019. Additionally, males suffered from a higher disease burden of these three cancers attributable to smoking than females. The elderly population had a higher smoking-attributable disease burden than the younger population. ConclusionThe situation of the disease burden of bladder, prostate and kidney cancers attributable to smoking is still serious in China, which has substantial disparities in different groups. Specifically, males and the elderly are the high-risk groups for the smoking-attributable burden. Among the three cancers, bladder cancer has the highest burden and kidney cancer has the largest burden increase during 1990-2019.

    Release date: Export PDF Favorites Scan
  • Development and preliminary validation of questionnaire for infection process and prevention of 2019 novel coronavirus infection in medical staffs

    ObjectiveTo develop the questionnaire and test its reliability for investigating route, prevention, and control of SARS-CoV-2 infection in medical staffs.MethodsThis questionnaire was development based on the COVID-19 relevant guidelines, official documents issued by the National Health Committee of the People's Republic of China, and published studies. The development group performed repeated discussions and drafted the first questionnaire, then performed expert consultation and revised the draft according to their suggestions. Eventually, some frontline medical staffs were invited to carry out pre-test investigation of the questionnaire and test its reliability.ResultsThe first draft included 48 items; 18 experts were invited in the first round questionnaire and 10 experts in the second round questionnaire. The positive coefficient of experts in these two rounds was both greater than 75%, and the authority coefficient of experts' opinions was greater than 0.70. The variation coefficient of these items was between 0.00 and 0.35, the coordination coefficient of experts was 0.193 (P<0.05). The experts of above two rounds put forward 14 suggestions for text modification or adjustment options of some items; after the development group held repeatedly discussions, a total of 8 items were performed secondary consultation and finally reached consensus. The final questionnaire included two domains of questionnaire before and after confirmed diagnosis. The domain "before confirmed diagnosis" covered 4 sections and 29 items involving infectious cause, plan and knowledge of prevention and control, and psychological symptoms. The domain "after confirmed diagnosis" covered 5 sections and 21 items, included symptoms, treatment, and psychological status after diagnosis; impact on the surrounding environment and people, and awareness of protection after infection. The pre-test results showed that the total items were considerably numerous, some items were difficult to understand, some laboratory results and treatment conditions were ambiguous, etc. After modification and re-testing, the test-re-test reliability of each domain was between 0.74 and 0.93, and the overall re-test reliability of the questionnaire content was 0.82.ConclusionsThis research has developed a questionnaire for investigating infection process, prevention and control of SARS-CoV-2 infection in medical staff, and the items considered two domains prior to and after confirmed diagnosis. The reliability and practicability of the questionnaire are acceptable.

    Release date:2020-07-02 09:18 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content